Financial anatomy of biomedical research

JAMA

Volumn 294, Issue 11, 2005, Pages 1333-1342

  Moses III, Hamilton ^a,b   Dorsey, E Ray ^d,e   Matheson, David H M ^b   Thier, Samuel O ^c  

^a Alerion Institute   (United States)

^b BOSTON CONSULTING GROUP   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DATA BASE; DEVICE; ECONOMIC ASPECT; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH SERVICE; INDUSTRY; MEDICAL RESEARCH; NON PROFIT ORGANIZATION; PRIORITY JOURNAL; PRODUCTIVITY; SOCIAL WELFARE; UNITED STATES; UNIVERSITY; ECONOMICS; ORGANIZATION AND MANAGEMENT;

BIOMEDICAL RESEARCH; PRIVATE SECTOR; PUBLIC SECTOR; RESEARCH SUPPORT; UNITED STATES;

EID: 25144518364     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.294.11.1333     Document Type: Article

References (49)

1. Hall P. The Innovative Milieu, in Cities in Civilization. New York, NY: Pantheon; 1998.
2. O'Mara M. Cities of Knowledge, Cold War Science and the Search for the Next Silicon Valley. Princeton, NJ: Princeton University Press; 2004.
3. US Census Bureau. Statistical Abstract of the United States, Science and Technology. Washington, DC: US Census Bureau; 1999.
4. Biotech 2010 Web page. Available at: http://www.massbiotech2010.org. Accessed June 19, 2005.
5. Trends in US Funding for Biomedical Research. San Francisco: The Center for the Health Care Professions, University of California, San Francisco; 1995. Available at: http://www.futurehealth.ucsf.edu/summaries/trends_summary.html. Accessed June 15, 2005.
6. Institute of Medicine. Strengthening Health Research in America: Philanthropy's Role. Washington, DC: National Academy Press; 1999.
7. National health accounts: definitions, sources, and methods used in the NHE 2003 services and products. Baltimore, Md: Centers for Medicare & Medicaid Services. Available at: http://www.cms.hhs.gov/statistics/nhe/ definitions-sources-methods/default-03.asp. Accessed June 16, 2005.
8. Biotech 2005 Life Sciences: A Move Towards Predictability. San Francisco: Burrill & Co LLC; 2005.
9. Biomedical research and development price index (BRDPI). Bethesda, Md: Office of Science and Policy Planning. Available at: http://ospp.od.nih.gov/ ecostudies/brdpi.asp. Accessed June 16, 2005.
10. Health Accounts. Baltimore, Md: Centers for Medicare & Medicaid Services. Available at: http://www.cms.hhs.gov/statistics/nhe. Accessed June 16, 2005.
11. National Health Accounts. Definitions, sources, and methods used in the NHE 2003 introduction. Baltimore, Md: Centers for Medicare & Medicaid Services. Available at: http://www.cms.hhs.gov/statistics/nhe/definitions- sources-methods/default.asp. Accessed June 16, 2005.
12. Federal Funds for Research and Development: Fiscal Years 2002, 2003, 2004. Arlington, Va: National Science Foundation Division of Science Resources Statistics; 2005. Publication No. NSF 05-307.
13. Foundation Growth and Giving Estimates. 2004 Preview. New York, NY: The Foundation Center; 2005.
14. Foundation Giving Trends 2000. New York, NY: The Foundation Center; 2001.
15. Foundation Giving Trends 2005. New York, NY: The Foundation Center; 2005.
16. Pharmaceutical Research and Manufacturers of America. Pharmaceutical Industry Profile 2005. Washington, DC: PhRMA; 2005.
17. Biotechnology industry facts. Washington, DC: Biotechnology Industry Organization. Available at: http://www.bio.org/speeches/pubs/er/statistics.asp. Accessed June 16, 2005.
18. Lawyer P, Kirstein A, Yabuki A, Gjaja M, Kush D. High science: a best-practice formula for driving innovation. In Vivo Business Med Rep. 2004;22:1-14. Available at: http://www.windhover.com/contents/monthly/exex/ e_2004800080.htm. Accessed August 23, 2005.
19. US Food and Drug Administration. Office of Device Evaluation. 2004 Annual Report. Rockville, Md: US Food and Drug Administration; 2004.
20. Pharmaceutical Industry Profile 2004. Washington, DC: Pharmaceutical Research and Manufacturers of America; 2004.
21. Pharmaceutical Industry Profile 2003. Washington, DC: Pharmaceutical Research and Manufacturers of America; 2003.
22. Pharmaceutical Industry Profile 2002. Washington, DC: Pharmaceutical Research and Manufacturers of America; 2002.
23. Pharmaceutical Industry Profile 2001. Washington, DC: Pharmaceutical Research and Manufacturers of America; 2001.
24. Pharmaceutical Industry Profile 2000. Washington, DC: Pharmaceutical Research and Manufacturers of America; 2000.
25. Pharmaceutical Industry Profile 1999. Washington, DC: Pharmaceutical Research and Manufacturers of America; 1999.
26. Pharmaceutical Industry Profile 1998. Washington, DC: Pharmaceutical Research and Manufacturers of America; 1998.
27. Pharmaceutical Industry Profile 1996. Washington, DC: Pharmaceutical Research and Manufacturers of America; 1996.
28. Academic Research and Development Expenditures: Fiscal Year 2002. Arlington, Va: National Science Foundation Division of Science Resources Statistics; 2004. Publication No. NSF 04-330.
29. Update on Foundation Health Policy Grantmaking. New York, NY: The Foundation Center; March 2004. Available at: http://fdncenter.org/research/ trends_analysis/pdf/update_health_policy.pdf. Accessed June 16, 2005.
30. Top 50 US Foundations Awarding Grants for Medical Research, circa 2003. New York, NY: The Foundation Center; 2005. Available at: http://fdncenter.org/ fc_stats/pdf/04_fund_sub/2003/50_found_sub/f_sub_h_03.pdf. Accessed June 16, 2005.
31. Lawler A, Mervis J. US science budget: science agencies caught in postelection spending squeeze. Science. 2004;306:1662-1663.
32. Booth B, Zemmel R. Prospects for productivity. Nat Rev Drug Discov. 2004;3:451-456.
33. Moses H III, Thier SO, Matheson DH. Why have academic medical centers survived? JAMA. 2005;293:1495-1500.
34. Jones RF, Sanderson SC. Clinical revenues used to support the academic mission of medical schools, 1992-93. Acad Med. 1996;71:299-307.
35. Weissman JS, Saglam D, Campbell EG, Causino N, Blumenthal D. Market forces and unsponsored research in academic health centers. JAMA. 1999;281:1093-1098.
36. Cohen W, Nelson R, Walsh J. Links and impacts: the influence of public research on industrial R&D. Manage Sci. 2002;48:1-23. Available at: http://www.extenza-eps.com/inf/doi/abs/10.1287/mnsc.48.1.1.14273. Accessed August 23, 2005.
37. Biotech pharmaceuticals from seed to harvest. Economist; June 2, 2005. Available at: http://www.economist.com/printedition/displayStory.cfm?Story_ID= 4034111. Accessed June 16, 2005.
38. Okie S. What ails the FDA? N Engl J Med. 2005;352:1063-1066.
39. Rosenberg RN. Translating biomedical research to the bedside: a national crisis and a call to action. JAMA. 2003;289:1305-1306.
40. Lawrence S. Corporate R&D scorecard 2004. Technol Rev. 2004;(December):68-71. Available at: http://www.techreview.com/articles/04/12/ scorecard1204.2.asp. Accessed August 23, 2005.
41. The Kaiser Family Foundation and Health Research and Educational Trust. Employer Health Benefits, 2004 Annual Survey. Menlo Park, Calif: Henry J. Kaiser Family Foundation; 2004.
42. Institute of Medicine. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000.
43. Schuster MA, McGlynn EA, Brook RH. How good is the quality of health care in the United States? Milbank Q. 1998;76:517-563.
44. Kovner AR. Agenda setting for health care management research: report of a conference. Health Care Manage Rev. 2003;28:319-322.
45. Kumar A, Ozdamar L. International comparison of health care systems. Intern J Computer Internet Manage. 2004;12:81-95.
46. Buxton M, Hanney S, Jones T. Estimating the economic value to societies of the impact of health research: a critical review. Bull World Health Organ. 2004;82:733-739.
47. Owen-Smith J, Riccaboni M, Pammolli F, Powell W. A comparison of US and European universityindustry relations in the life sciences. Manage Sci. 2002; 48:24-43. Available at: http://www.extenza-eps.com/inf/doi/abs/10.1287/mnsc.48. 1.24.14275. Accessed August 23, 2005.
48. Callahan D. What Price Better Health? Hazards of the Research Imperative. Berkeley: University of California Press; 2003.
49. Osterholm MT. Preparing for the next pandemic. N Engl J Med. 2005;352:1839-1842.